A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?
- Status
- COMPLETED
- Phase
- PHASE4
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Mail Outreach To Increase Vaccination Acceptance Through Engagement
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age
- Status
- COMPLETED
- Phase
- PHASE3
Banlangen Granules Anti-seasonal Influenza Study
- Status
- UNKNOWN
- Phase
- PHASE4
Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children
- Status
- COMPLETED
- Phase
- PHASE3
H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...
- Status
- COMPLETED
- Phase
- PHASE1
Influenza Immunization in Adults Over Age 75
- Status
- RECRUITING
- Phase
- NA
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age
- Status
- WITHDRAWN
- Phase
- PHASE1
Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics
- Status
- COMPLETED
- Phase
- NA
Impact of Influenza Vaccination in Pregnancy Video Education
- Status
- COMPLETED
- Phase
- NA